Long-term repeatability and stability of three personality traits in meadow voles

Consistency of animal personality traits is expected. Mounting evidence suggests that animal personalities will change with time and major life events. Research into this phenomenon is often limited to span only short periods of time in the animals’ life or have few measures across their life. We measured Exploration, Activity and Boldness of litters of meadow voles, Microtus pennsylvanicus, in a pair of novel object tests six times over a year, representing a large proportion of the lifespan of the vole. Our null hypothesis was that the personality traits would not change, and our first alternative hypothesis was that personality traits would change equally for all individuals as they aged. Neither was supported. The data support our third hypothesis that traits would change and change unequally. Activity and Boldness were consistent across time. However, Exploratory behaviour increased with the vole's age. The supported models show that personality traits change consistently for related individuals, but the litters differ in their change with age. This suggests that meadow vole life history affects how personality traits develop, but not necessarily their magnitudes. We also tested the repeatability of traits across the testing intervals. We discovered that the repeatability of these three personality traits varied across time, depending on the trait. Activity was repeatable equally across ages. Exploration became more repeatable and Boldness became less so. Thus, personality traits may be more malleable than supposed, especially over long periods of time.     

Methode und Gerät zur Untersuchung des Wanderungsvermögens von Fritfliegenlarven

Schwantes, H.O.: Biologie der Pilze. Eine Einführung in die angewandte Mykologie. 478 S., 60 Abb., 29 Tab. Verlag Eugen Ulmer, Stuttgart, 1996, UNI‐Taschenbücher 1871, 42,80 DM. ISBN 3–8252–1871–6

Westhoff, P.; Jeske, H.; Jürgens, G.; Kloppstock, K.; Link, G.: Molekulare Entwicklungsbiologie. Vom Gen zur Pflanze. Georg Thieme Verlag Stuttgart, New York; 1996; 112 Abb., 19 Tab. ISBN 3–13–102021–0

McNamara, K.J. (Herausgeber): Evolutionary Change and Heterochrony. John Wiley &; Sons; Chichester, New York, Brisbane, Toronto, Singapur (1995), ISBN 0–471–95837–9

Sobral, B.W.S. (Herausgeber): The Impact of Plant Molecular Genetics. Birkhäuser Verlag AG Basel (1996), ISBN 3–7643–3802–4

McIntosh, R.A.; Wellings, C.R.; Park, R.F.: Wheat rusts ‐ An atlas of resistance genes. 200 S., 119 Bildseiten, Kluwer Academic Publishers, Dordrecht, Boston, London, 1995, 125,00 Dfl., ISBN 0–7923–3430–2

Friedrich, G.; Rode, H. (Hsg.): Pflanzenschutz im integrierten Obstbau. Verlag Eugen Ulmer Stuttgart. 1996. 494 S., 128 Farbfotos, 94 Zeichnungen, 41 Tab., 3. völlig neubearbeitete Auflage. Preis 88,‐DM; ISBN 3–8001–5541–9

Nultsch, W.: Allgemeine Botanik. 10. neubearbeitete erweiterte Auflage. Georg Thieme Verlag Stuttgart New York. 1996, 602 Seiten, 234 Abb. in 525 Einzeldarstellungen, 19 Boxen. Glossarium mit 752 Stichworten. Preis 44,‐DM; ISBN 3–13–383310–3

Berndt, J.: Umweltbiochemie. Uni‐Taschenbücher 1838. Gustav Fischer Verlag Stuttgart Jena. 1995; 278 S., 101 Abb., 33 Tab., Preis 34.80 DM. UTB‐ISBN 3–8252–1838–4

Kalusche, D.: Ökologie in Zahlen. Eine Datensammlung in Tabellen mit über 10.000 Einzelwerten. Gustav Fischer Verlag. Stuttgart, Jena, New York. 1996. 415 S. Preis 54, ‐DM; ISBN 3–437–20521–8     

The population genetics of the Jewish people

Adherents to the Jewish faith have resided in numerous geographic locations over the course of three millennia. Progressively more detailed population genetic analysis carried out independently by multiple research groups over the past two decades has revealed a pattern for the population genetic architecture of contemporary Jews descendant from globally dispersed Diaspora communities. This pattern is consistent with a major, but variable component of shared Near East ancestry, together with variable degrees of admixture and introgression from the corresponding host Diaspora populations. By combining analysis of monoallelic markers with recent genome-wide variation analysis of simple tandem repeats, copy number variations, and single-nucleotide polymorphisms at high density, it has been possible to determine the relative contribution of sex-specific migration and introgression to map founder events and to suggest demographic histories corresponding to western and eastern Diaspora migrations, as well as subsequent microevolutionary events. These patterns have been congruous with the inferences of many, but not of all historians using more traditional tools such as archeology, archival records, linguistics, comparative analysis of religious narrative, liturgy and practices. Importantly, the population genetic architecture of Jews helps to explain the observed patterns of health and disease-relevant mutations and phenotypes which continue to be carefully studied and catalogued, and represent an important resource for human medical genetics research. The current review attempts to provide a succinct update of the more recent developments in a historical and human health context.     

Species‐specific detection of the antiviral small‐molecule compound CMA by STING

Extensive research on antiviral small molecules starting in the early 1970s has led to the identification of 10‐carboxymethyl‐9‐acridanone (CMA) as a potent type I interferon (IFN) inducer. Up to date, the mode of action of this antiviral molecule has remained elusive. Here we demonstrate that CMA mediates a cell‐intrinsic type I IFN response, depending on the ER‐resident protein STING. CMA directly binds to STING and triggers a strong antiviral response through the TBK1/IRF3 route. Interestingly, while CMA displays extraordinary activity in phosphorylating IRF3 in the murine system, CMA fails to activate human cells that are otherwise responsive to STING ligands. This failure to activate human STING can be ascribed to its inability to bind to the C‐terminal ligand‐binding domain of human STING. Crystallographic studies show that two CMA molecules bind to the central Cyclic diguanylate ( c‐diGMP)‐binding pocket of the STING dimer and fold the lid region in a fashion similar, but partially distinct, to c‐diGMP. Altogether, these results provide novel insight into ligand‐sensing properties of STING and, furthermore, unravel unexpected species‐specific differences of this innate sensor.     

Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey

Background:

Chronic kidney disease is an important risk factor for death and cardiovascular-related morbidity, but estimates to date of its prevalence in Canada have generally been extrapolated from the prevalence of end-stage renal disease. We used direct measures of kidney function collected from a nationally representative survey population to estimate the prevalence of chronic kidney disease among Canadian adults.

Methods:

We examined data for 3689 adult participants of cycle 1 of the Canadian Health Measures Survey (2007–2009) for the presence of chronic kidney disease. We also calculated the age-standardized prevalence of cardiovascular risk factors by chronic kidney disease group. We cross-tabulated the estimated glomerular filtration rate (eGFR) with albuminuria status.

Results:

The prevalence of chronic kidney disease during the period 2007–2009 was 12.5%, representing about 3 million Canadian adults. The estimated prevalence of stage 3–5 disease was 3.1% (0.73 million adults) and albuminuria 10.3% (2.4 million adults). The prevalence of diabetes, hypertension and hypertriglyceridemia were all significantly higher among adults with chronic kidney disease than among those without it. The prevalence of albuminuria was high, even among those whose eGFR was 90 mL/min per 1.73 m² or greater (10.1%) and those without diabetes or hypertension (9.3%). Awareness of kidney dysfunction among adults with stage 3–5 chronic kidney disease was low (12.0%).

Interpretation:

The prevalence of kidney dysfunction was substantial in the survey population, including individuals without hypertension or diabetes, conditions most likely to prompt screening for kidney dysfunction. These findings highlight the potential for missed opportunities for early intervention and secondary prevention of chronic kidney disease.Chronic kidney disease is defined as the presence of kidney damage or reduced kidney function for more than 3 months and requires either a measured or estimated glomerular filtration rate (eGFR) of less than 60 mL/min per 1.73 m², or the presence of abnormalities in urine sediment, renal imaging or biopsy results.¹ Between 1.3 million and 2.9 million Canadians are estimated to have chronic kidney disease, based on an extrapolation of the prevalence of end-stage renal disease.² In the United States, the 1999–2004 National Health and Nutrition Examination Survey reported a prevalence of 5.0% for stage 1 and 2 disease and 8.1% for stage 3 and 4 disease.^3,4Chronic kidney disease has been identified as a risk factor for death and cardiovascular-related morbidity and is a substantial burden on the health care system.^1,5 Hemodialysis costs the Canadian health care system about $60 000 per patient per year of treatment.¹ The increasing prevalence of chronic kidney disease can be attributed in part to the growing elderly population and to increasing rates of diabetes and hypertension.^1,6,7Albuminuria, which can result from abnormal vascular permeability, atherosclerosis or renal disease, has gained recognition as an independent risk factor for progressive renal dysfunction and adverse cardiovascular outcomes.^8–10 In earlier stages of chronic kidney disease, albuminuria has been shown to be more predictive of renal and cardiovascular events than eGFR.^4,9 This has prompted the call for a new risk stratification for cardiovascular outcomes based on both eGFR and albuminuria.¹¹A recent review advocated screening people for chronic kidney disease if they have hypertension, diabetes, clinically evident cardiovascular disease or a family history of kidney failure or are more than 60 years old.⁴ The Canadian Society of Nephrology published guidelines on the management of chronic kidney disease but did not offer guidance on screening.¹ The Canadian Diabetes Association recommends annual screening with the use of an albumin:creatinine ratio,¹² and the Canadian Hypertension Education Program guideline recommends urinalysis as part of the initial assessment of hypertension.¹³ Screening for chronic kidney disease on the basis of eGFR and albuminuria is not considered to be cost-effective in the general population, among older people or among people with hypertension.¹⁴The objective of our study was to use direct measures (biomarkers) of kidney function to generate nationally representative, population-based prevalence estimates of chronic kidney disease among Canadian adults overall and in clinically relevant groups.